Loading organizations...
Agricultural technology company improving environmental and human health.
Arcadia Biosciences has raised $50.9M across 4 funding rounds.
Arcadia Biosciences has raised $50.9M in total across 4 funding rounds.
Arcadia Biosciences has raised $50.9M in total across 4 funding rounds.
Arcadia Biosciences's investors include Uday Garg, BASF Venture Capital, CMEA Capital, Saints Capital, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Exeter Life Sciences.
Arcadia Biosciences has raised $50.9M across 4 funding rounds. Most recently, it raised $33.0M Series D in May 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 8, 2014 | $33.0M Series D | Uday Garg | BASF Venture Capital, CMEA Capital, Saints Capital |
| Oct 3, 2013 | $2.0M Grant | National Institutes of Health | |
| Feb 15, 2010 | $860K Grant | National Institute of Diabetes and Digestive and Kidney Diseases | |
| Oct 29, 2008 | $15.0M Other Equity | Exeter Life Sciences | BASF Venture Capital, CMEA Capital, Saints Capital |